CHAIR
:
SPEAKER
(S):
Roger Lias
John Lewis, Vice President, MedImmune, Inc.
Gerald Geisler, Director of Engineering, North America and Puerto Rico, Bristol-Myers Squibb
Description
This session will review the latest trends, strategies and techniques that industry leaders use to execute complex large-scale bioprocess facilities in a regulated environment. Aspects of biopharmaceutical facility delivery, including strategic planning, programming, integrated facility design, and fast track commissioning and qualification will be explored.
Objectives:
Detail, using case studies of actual projects, the critical elements and execution through the different stages of recently delivered large-scale biopharmaceutical projects.
Present current industry trends and techniques used by leading biologics manufacturers for project strategic planning, programming and delivery.
Focus on the critical elements that have resulted in the successful completion of large-scale biopharmaceutical projects and the tools and techniques used to develop and implement plans for their execution.